about
Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signalingSelf-Reported Reproductive Tract Infections and Ultrasound Diagnosed Uterine Fibroids in African-American Women.Animal models of tumorigenic herpesviruses--an updateHsp90 inhibitors are efficacious against Kaposi Sarcoma by enhancing the degradation of the essential viral gene LANA, of the viral co-receptor EphA2 as well as other client proteinsKSHV Latency Locus Cooperates with Myc to Drive Lymphoma in MicePre-micro RNA signatures delineate stages of endothelial cell transformation in Kaposi sarcoma.Efficiency clustering for low-density microarrays and its application to QPCR.Profiling of pre-micro RNAs and microRNAs using quantitative real-time PCR (qPCR) arrays.A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirusAIDS related malignancies in Brazil.Targeted therapy for Kaposi's sarcoma and Kaposi's sarcoma-associated herpesvirus.Burkitt lymphoma in Brazil is characterized by geographically distinct clinicopathologic features.Whole-genome transcription profiling of rhesus monkey rhadinovirus.Regulation of the hepatitis C virus RNA replicase by endogenous lipid peroxidation.Zidovudine-based lytic-inducing chemotherapy for Epstein-Barr virus-related lymphomas.Molecular and clinical assessment in the treatment of AIDS Kaposi sarcoma with valproic AcidViral profiling identifies multiple subtypes of Kaposi's sarcoma.Methylene blue photoinactivation of RNA viruses.Tissue specificity of the Kaposi's sarcoma-associated herpesvirus latent nuclear antigen (LANA/orf73) promoter in transgenic miceComplete genome sequence of cell culture-attenuated Guinea pig cytomegalovirus cloned as an infectious bacterial artificial chromosomeMethylene blue photoinactivation abolishes West Nile virus infectivity in vivo.Interleukin 1 receptor-associated kinase 1 (IRAK1) mutation is a common, essential driver for Kaposi sarcoma herpesvirus lymphoma.Dual inhibition of phosphatidylinositol 3-kinase/mammalian target of rapamycin and mitogen activated protein kinase pathways in non-Hodgkin lymphomaSystemically circulating viral and tumor-derived microRNAs in KSHV-associated malignancies.Early experience after developing a pathology laboratory in Malawi, with emphasis on cancer diagnosesIdentification of human papillomaviruses from formalin-fixed, paraffin-embedded pre-cancer and invasive cervical cancer specimens in Zambia: a cross-sectional studyEpstein-Barr virus microRNAs and lung cancer.Overview of the oral HIV/AIDS Research Alliance Program.Viral latent proteins as targets for Kaposi's sarcoma and Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) induced lymphoma.Tumor suppressor genes FHIT and WWOX are deleted in primary effusion lymphoma (PEL) cell lines.Toll-like receptor-3 is dispensable for the innate microRNA response to West Nile virus (WNV).Human cytomegalovirus gene expression in long-term infected glioma stem cells.Functional p53 signaling in Kaposi's sarcoma-associated herpesvirus lymphomas: implications for therapy.High Accuracy of Common HIV-Related Oral Disease Diagnoses by Non-Oral Health Specialists in the AIDS Clinical Trial Group.Multicentric Castleman's disease in MalawiAzidothymidine inhibits NF-kappaB and induces Epstein-Barr virus gene expression in Burkitt lymphomaCharacteristics and survival for HIV-associated multicentric Castleman disease in Malawi.Complete Genome Sequences of Mandrillus leucophaeus and Papio ursinus Cytomegaloviruses.Clinical Factors Associated with Long-Term Complete Remission versus Poor Response to Chemotherapy in HIV-Infected Children and Adolescents with Kaposi Sarcoma Receiving Bleomycin and Vincristine: A Retrospective Observational StudyKaposi's sarcoma in the era of HAART-an update on mechanisms, diagnostics and treatment.
P50
Q24673299-A57173F3-ED37-4154-B896-8D4F6C9ECA66Q27307658-ACCD0AAA-C2CB-47FE-8441-0178B0B52CD2Q28083747-000FE5E5-0BD5-4CB2-AC25-1B70D4A20846Q28485399-FCB6DE41-4E71-42CF-AC38-01F28CAAFDD5Q28547671-B10230B4-8926-4EF1-8ACE-B7A205859AD0Q33432690-92FA3469-DD30-4222-A953-4D95883E5CCCQ33636834-6410DFA3-B745-4621-B5B4-73FA102D7216Q33778153-721909F4-C697-4D87-B503-24FEC17843A1Q33784966-0A1034C3-4104-47CF-9D16-21F9C0486972Q33793515-E37D2D70-7596-47DF-9B80-992CF6A0953BQ33793543-51A2384E-2E8F-42DD-ACF9-DFF40B0B457CQ33835215-E3647F2A-7506-4F30-98D1-365ACCEFB51BQ33843286-FF7E281E-72D3-4F6F-A57B-E7D8C308701BQ34020915-DB7A95BB-DD48-49D9-96D0-F03C72DFF69EQ34053519-77C99E6C-5BFE-4DB0-9ECF-B82C8F595D58Q34187225-DCD839EC-8A3B-43F5-AE38-AF44F8A528FEQ34237734-67556732-F18F-4D91-B52F-5354A98E292EQ34323564-EE4A5108-25E7-4EE9-AB44-EF12DB1B5026Q34349469-01AA9550-2DFB-4DB4-91CB-0AE9B23FE0AAQ34354971-0AFE85B3-064A-4993-9C26-146FD616851DQ34445045-32D6A3C1-9C4F-45E4-B3C0-78AA919FB507Q34480968-77C4E776-1BE1-4B57-B156-398BD1D18EFAQ34644692-6A4E9BCC-3632-4059-B8CD-FF33F5E4E731Q34845533-5FD3598F-6096-4978-B0C8-57FBAAC362C1Q34946764-F139F07F-603F-4C9D-9D9A-14046A5ABE4AQ35006526-6D7C3257-BFF9-4E20-BD1A-6BC4BC53C474Q35125635-22F8E3F1-E803-41AB-ACF2-6FC0C6B4F02EQ35129078-3EDCB78E-D55F-49B1-9647-A8ECFA6D2C85Q35137851-14C11DE5-441C-4831-9B91-9B55B2258531Q35172518-EC236F50-AEA8-4036-81EA-66E76B297282Q35225674-F784D7DA-E8E5-4AF2-A7D1-2F16CB14D40CQ35535809-5029EB37-4A17-4A7D-828B-5951D8D22F13Q35635426-6546BFD3-5FFD-4839-9D74-8E4A51ED6775Q35684289-13BABBE2-8319-4CCB-A0C2-BDA26499AB2DQ35751306-CB7BDAE8-7D23-4C2C-9808-303ABB75B2F6Q35847814-60D35B24-F3A2-4D64-B7C0-CF24690E6FBDQ35916171-9D0A5152-6673-499B-AD7B-3D91C5ABEBE4Q35969761-83B75E5F-9549-4F7E-BAF7-4F579C9EF627Q35991165-3EC5E5E1-7B73-4D2F-AFDB-28AD60C4CBC7Q36117364-BD620B12-C826-4926-84F1-A58B54147199
P50
description
researcher
@en
wetenschapper
@nl
name
D Dittmer
@en
D Dittmer
@nl
type
label
D Dittmer
@en
D Dittmer
@nl
prefLabel
D Dittmer
@en
D Dittmer
@nl
P106
P31
P496
0000-0003-4968-5656